Lung Cancer - Second of Four Phase 2 Clinical Trials of OGX-011

OncoGenex Technologies Inc, announcedtoday that the first patient has been treated in a Phase 2 clinical trial ofOGX-011 in combination with gemcitabine and cisplatin (GEM/CIS) inchemotherapy naive patients with advanced non-small cell lung cancer (NSCLC)... click link for more info.

Continue to Lung Cancer - Second of Four Phase 2 Clinical Trials of OGX-011 on Medical News Today.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz